Company Directory / Biotechnology

OncoDNA logo

PrivateFor profitBiotechnologyGosselies, Walloon Region, Belgium

OncoDNA

OncoDNA is a company specialized in precision medicine for the treatment of cancer.

Founded
2012
14 years ago
Staff
101-250
50 on LinkedIn
Followers
14k
on LinkedIn
Funding
$27M
as listed, USD

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its… Read all

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker testing, data interpretation software, and clinical decision support tools. OncoDNA is headquartered in Belgium, and its entities – Biosequence and IntegraGen – are based in Spain, France and the United States. The Group employs over 100 employees across 9 countries, works with an international network of 35 distributors and collaborates with both European-based and US-based subcontracted accredited laboratories.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

101-250 people: larger than 85% of companies with a size listed. 50 people list it on LinkedIn.

Age

201219002026

14 years old.

Reach

Website ranked #7,270,168 in the world for traffic, about 832 visits a month. 14,236 followers on LinkedIn.

What it does

BiotechnologyHealth CareHealth DiagnosticsPrecision Medicinebioinformaticstheranosticsmolecular diagnosticsbiomarker testinggenomicsoncologyprecision medicine

Funding, as listed

$27M raised in total

  • Rounds2
  • LatestSeries b, Feb 2020
  • Latest amountUSD 20,577,959
  • Investors9, 3 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersFrançois Blondel, Jean-Pol Detiffe
Apps1

Every detail we hold

Everything the source datasets list about OncoDNA, field by field. Contact details are held but never shown.

The company

Name
OncoDNA
Type
For profit
Status
Private
Founded
2012
Founders
François Blondel, Jean-Pol Detiffe
Industry
Biotechnology
Categories
Biotechnology, Health Care, Health Diagnostics, Precision Medicine
Specialities
bioinformatics, theranostics, molecular diagnostics, biomarker testing, genomics, oncology, precision medicine

Where

City
Gosselies
Region
Walloon Region
Country
Belgium
Markets
European Union (EU), Europe, Middle East, and Africa (EMEA)

Size and reach

Staff band
101-250
People on LinkedIn
50
LinkedIn followers
14,236
Web traffic rank
#7,270,168
Monthly web visits
832
Apps
1

Funding, as listed

Total
$26,700,000 USD
Rounds
2
Latest round
Series b
Latest round date
Feb 2020
Latest amount
20,577,959 USD
Investors
9
Lead investors
3
Listing status
private

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

OncoDNA may be growing as evidenced by the launch of the OncoDEEP Solid Tumor Biomarker Test in February 2022, which indicates an expansion of their product offerings. The company is also listed among other key players in the cancer profiling market, suggesting a competitive presence in the industry. Furthermore, the mention of OncoDNA in the context of a campaign post COVID-19 implies ongoing marketing efforts and potential market engagement.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Biotechnology in Belgium.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,920 companies in Belgium and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.